[Cardiac troponins - biomarkers for cardiovascular disease in chronic obstructive pulmonary disease]

Mikael Michelini Truedsson1, Martin Stagmo2, Ingrid Alm Hirsch3

  • 1Capio, Limhamn - vårdcentral Malmö, Sweden Capio, Limhamn - vårdcentral Malmö, Sweden.

Lakartidningen
|February 26, 2020
PubMed

Insights

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) frequently coexist. Elevated cardiac troponins in COPD patients, even when stable, indicate myocardial injury and link these conditions.

Area of Science:

  • Cardiology
  • Pulmonology
  • Biomarkers

Background:

  • Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) share risk factors and pathophysiological pathways.
  • COPD is an independent risk factor for CVD, with common comorbidities including ischemic heart disease, heart failure, pulmonary hypertension, and atrial fibrillation.

Purpose of the Study:

  • To discuss the intricate association between COPD, CVD, and cardiac troponin elevation.
  • To explore the mechanisms behind elevated troponin levels in both stable and exacerbated COPD.

Main Methods:

  • Literature review and synthesis of existing research on COPD, CVD, and cardiac troponins.
  • Analysis of studies investigating cardiac troponin levels in COPD patients.

Main Results:

  • Cardiac troponin elevation is observed in both stable and acutely exacerbated COPD.
  • Elevated troponins in COPD signify myocardial injury, highlighting the cardiac implications of this pulmonary condition.

Conclusions:

  • The link between COPD, CVD, and cardiac troponins is significant and warrants further investigation.
  • Understanding these associations is crucial for comprehensive patient management and risk stratification.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
707
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
472
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
154
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K